Lynx Extends Service Contract with DuPont | GenomeWeb

NEW YORK, Nov. 11 (GenomeWeb News) - Lynx Therapeutics said today that it has signed a multi-year, multi-million dollar services agreement with DuPont that extends a five-year agreement the companies initiated in 1998.

Under the extended arrangement, DuPont and its subsidiary, Pioneer Hi-Bred International, will continue using Lynx's Massively Parallel Signature Sequencing (MPSS) technology for the discovery and development of new agricultural traits and products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.